Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02063191 · ClinicalTrials.gov registry record

Activation Timing and Atrial Fibrillation

A clinical trial, sponsored by Essentia Health.

Terminated
Registry status
3
Enrollment target

NCT02063191 is a clinical trial that was terminated before completion, run by Essentia Health. The registered enrollment target is 3 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02063191 was terminated before completion, sponsored by Essentia Health.

TERMINATED
Registry status
3 participants
Enrollment target

Study Summary

This is a single center, non-randomized, unblinded study of patients who are followed at Essentia Health - St. Mary's Medical Center and who are referred for a clinically indicated diagnostic electrophysiology (EP) study with or without ablation. During the procedure, events of atrial fibrillation, sinus rhythm and bundle branch block that may occur during the course of the case will be saved electronically and analyzed offline. The stored data will be evaluated off-line for changes in activation timing of the near and far field ventricular signals of the stored events. This proof-of-concept study will attempt to assess whether atrial fibrillation, or bundle branch block can change activation timing compared to baseline sinus rhythm. If no significant activation change is seen, then this finding can be used as a basis to distinguish ventricular tachycardia from atrial fibrillation in future rhythm discrimination methods.

Trial Details

FieldValue
Enrollment Target 3 participants
Start Date 2014-01
Est. Completion 2014-11

Sponsor

Essentia Health

17 total trials

What the Registry Record Tells You About NCT02063191

The ClinicalTrials.gov registry entry for NCT02063191 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Essentia Health, which has 17 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT02063191 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02063191 about?

NCT02063191 is a clinical study titled "Activation Timing and Atrial Fibrillation". This is a single center, non-randomized, unblinded study of patients who are followed at Essentia Health - St. Mary's Medical Center and who are referred for a clinically indicated diagnostic electrophysiology (EP) study with or without ablation. During the procedure, events of atrial fibrillation, ...

What is the current status of trial NCT02063191?

This trial is currently terminated. The enrollment target is 3 participants. The study started on 2014-01. Estimated completion is 2014-11.

Who is sponsoring clinical trial NCT02063191?

This trial is sponsored by Essentia Health, which has 17 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.